is trulicity a glp 1 inhibitor Comparing Ozempic, Wegovy and Other GLP-1 Drugs Evolution of GLP‐1 Receptor Agonists

The focus on sustainable approaches for health is so important

doi: 10.1016/j.molmet.2020.101102 [DOI] [PMC free article] [PubMed] [Google Scholar] 11

The only difference is concentration

or GLP-1 receptor agonist (n = 11,395) vs

While not all of these uses are proven (and some may never be), the fact that semaglutide is being investigated for so many different conditions is very exciting, especially for those with PMOS

With the obesity epidemic contributing to rising rates of diabetes, heart disease and other chronic conditions, GLP-1 therapies represent a potential turning point in the fight against these diseases